Viewing Study NCT07349693


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 5:29 AM
Study NCT ID: NCT07349693
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-20
First Post: 2026-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma
Sponsor: Everfront Biotech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module